Andrea Lukács1, Krisztina Mayer1, Péter Sasvári2,3, László Barkai1,4. 1. Faculty of Health Care, University of Miskolc, Miskolc-Egyetemváros, Hungary. 2. Faculty of Mechanical Engineering and Informatics, University of Miskolc, Miskolc-Egyetemváros, Hungary. 3. National University of Public Service, Budapest, Hungary. 4. Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Kosice, Košice, Slovakia.
Abstract
BACKGROUND: Adolescents with type 1 diabetes (T1D) can be faced with deterioration in glycemic control (GC), reduced health-related quality of life (HRQoL), and other psychosocial problems. It is important to understand how the disease and its clinical conditions influence HRQoL and how adolescents are able to overcome the life adjustment difficulties. OBJECTIVE: To assess HRQoL of adolescents with T1D from demographic, clinical, personal, and behavioral point of view. SUBJECTS: A total of 229 adolescents with T1D (51.2% males) with a mean age of 15.35 (2.29) years old were recruited from three diabetes centers. The mean diabetes duration was 7.48 (3.87), the mean hemoglobin A1C (HbA1c) level was 10.3 (1.76) mmol/L. METHODS: A multicenter quantitative correlational design study was applied to investigate the influence of sex, age, diabetes duration, GC expressed by HbA1c, intensive insulin regimen, physical activity (PA), resilience (RS), and socioeconomic background on HRQoL. RESULTS: Presence of the diabetes symptoms and worry about the disease has negative impact on the patients' HRQoL. Stepwise multiple regression analyses indicated that insulin pump therapy, male sex, and higher level of RS were significantly related to an increase in HRQoL, whereas the higher level of PA, male sex, and better HRQoL was significantly related to positive change in RS. Patients treated with insulin pump therapy had significantly better HRQoL. CONCLUSIONS: Significant association can be observed between HRQoL and RS. Supposedly, higher level of PA promotes higher level of RS that in turn helps increase HRQoL in adolescents with T1D. Treatment with insulin pump therapy also promotes better HRQoL.
BACKGROUND: Adolescents with type 1 diabetes (T1D) can be faced with deterioration in glycemic control (GC), reduced health-related quality of life (HRQoL), and other psychosocial problems. It is important to understand how the disease and its clinical conditions influence HRQoL and how adolescents are able to overcome the life adjustment difficulties. OBJECTIVE: To assess HRQoL of adolescents with T1D from demographic, clinical, personal, and behavioral point of view. SUBJECTS: A total of 229 adolescents with T1D (51.2% males) with a mean age of 15.35 (2.29) years old were recruited from three diabetes centers. The mean diabetes duration was 7.48 (3.87), the mean hemoglobin A1C (HbA1c) level was 10.3 (1.76) mmol/L. METHODS: A multicenter quantitative correlational design study was applied to investigate the influence of sex, age, diabetes duration, GC expressed by HbA1c, intensive insulin regimen, physical activity (PA), resilience (RS), and socioeconomic background on HRQoL. RESULTS: Presence of the diabetes symptoms and worry about the disease has negative impact on the patients' HRQoL. Stepwise multiple regression analyses indicated that insulin pump therapy, male sex, and higher level of RS were significantly related to an increase in HRQoL, whereas the higher level of PA, male sex, and better HRQoL was significantly related to positive change in RS. Patients treated with insulin pump therapy had significantly better HRQoL. CONCLUSIONS: Significant association can be observed between HRQoL and RS. Supposedly, higher level of PA promotes higher level of RS that in turn helps increase HRQoL in adolescents with T1D. Treatment with insulin pump therapy also promotes better HRQoL.
Authors: Marisa E Hilliard; Viena T Cao; Sahar S Eshtehardi; Charles G Minard; Rana Saber; Debbe Thompson; Lefkothea P Karaviti; Barbara J Anderson Journal: Diabetes Technol Ther Date: 2020-05-22 Impact factor: 6.118
Authors: Shivani Agarwal; Lauren G Kanapka; Jennifer K Raymond; Ashby Walker; Andrea Gerard-Gonzalez; Davida Kruger; Maria J Redondo; Michael R Rickels; Viral N Shah; Ashley Butler; Jeffrey Gonzalez; Alandra S Verdejo; Robin L Gal; Steven Willi; Judith A Long Journal: J Clin Endocrinol Metab Date: 2020-08-01 Impact factor: 5.958
Authors: Madelon B Bronner; Mariëlle A C Peeters; Jane N T Sattoe; AnneLoes van Staa Journal: Health Qual Life Outcomes Date: 2020-05-12 Impact factor: 3.186